Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADRAMIO: adrenaline versus amiodarone for out-of-hospital cardiac arrest with shockable rhythms
2013-004317-40Phase 3Terminated
- Sponsor
- The Heart Centre, Rigshospitalet
- Start
- Feb 2014
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of amiodarone and epinephrine in cardiac arrest (SCA), ventricular fibrillation (VF) and pulseless ventricular tachycardia (2 arms), sponsored by The Heart Centre, Rigshospitalet. Primary endpoint: Survival to hospital discharge. Started Feb 2014; status: terminated.
02
Drugs
amiodaroneepinephrine
03
Conditions
cardiac arrest (SCA)ventricular fibrillation (VF)pulseless ventricular tachycardia
Beyond the preview
Go deeper on 2013-004317-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004317-40.